OĞUZÜLGEN, İ. K. Et Al. 2023. Real-world patient-level costeffectiveness analysis of omalizumab in patients with severe allergic asthma. EUROPEAN RESPIRATORY JOURNAL .

OĞUZÜLGEN, İ. K., Tugay, D., TOP, M., AYDIN, Ö., BAVBEK, S., DAMADOĞLU, E., ... Erkekol, F. O.(2023). Real-world patient-level costeffectiveness analysis of omalizumab in patients with severe allergic asthma. EUROPEAN RESPIRATORY JOURNAL .

OĞUZÜLGEN, İPEK Et Al. "Real-world patient-level costeffectiveness analysis of omalizumab in patients with severe allergic asthma," EUROPEAN RESPIRATORY JOURNAL , 2023

OĞUZÜLGEN, İPEK K. Et Al. "Real-world patient-level costeffectiveness analysis of omalizumab in patients with severe allergic asthma." EUROPEAN RESPIRATORY JOURNAL , 2023

OĞUZÜLGEN, İ. K. Et Al. (2023) . "Real-world patient-level costeffectiveness analysis of omalizumab in patients with severe allergic asthma." EUROPEAN RESPIRATORY JOURNAL .

@article{article, author={İPEK KIVILCIM OĞUZÜLGEN Et Al. }, title={Real-world patient-level costeffectiveness analysis of omalizumab in patients with severe allergic asthma}, journal={EUROPEAN RESPIRATORY JOURNAL}, year=2023}